Remove Drugs Remove Genetic Analysis Remove Reagent
article thumbnail

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

The Pharma Data

Food and Drug Administration (FDA). ” With the panel’s authorization, Agena also aims to alleviate material shortages, enabling laboratories to accelerate testing without concerns about instrument or reagent availability. SAN DIEGO , Oct. ” More information is available at www.agenabio.com. About Agena Bioscience.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

This blog highlights the top 10 biotech trends for 2025, showcasing cutting-edge technologies and approaches that promise to redefine patient care, accelerate drug development and expand our understanding of human biology. The global next-generation biomanufacturing market is projected to grow at a CAGR of 14.85 billion by 2031.